Published: 2021-03-23

Neonatal thrombocytopenia and associated factors

Nandini Sodha, Nehil Nigam, Gunjan Kela


Background: The aim is to study neonatal thrombocytopenia and associated factors and compare the results with recent studies in neonates with thrombocytopenia admitted in neonatal intensive care unit (NICU).

Methods: After taking detailed consent from parents/guardians, detailed maternal obstetrics and neonatal history were taken and complete physical examination was done and details of the investigations done and outcome was noted and evaluated. Relevant data was entered in the predesigned proforma and was analyzed. Immediate outcome was assessed by outcome or death.

Results: The most common cause of neonatal thrombocytopenia was preterm gestational age. There were 68 (27.2%) neonates in the age group 28-32 weeks, 107 (42.8%) were in the age group 32-37 weeks and 75 (27.2%) were in the age group 37-42 weeks. Majority of the neonates were in the age group 32-37 weeks. We assessed outcome which was as follows, 98 (39.2%) neonates had expired and 152 (60.8%) neonates had survived in our study.

Conclusions: We studied the etiology of neonatal thrombocytopenia and associated factors. The most common cause of neonatal thrombocytopenia found was preterm gestational age. The most common type of neonatal thrombocytopenia found in our study was moderate to severe thrombocytopenia. In our study, there was 39.6% was neonatal death rate. In our study, neonatal thrombocytopenia was associated with the following factors gestational age, intrauterine growth retardation, pre-eclampsia, multiple pregnancy, eclampsia, birth asphyxia, x-ray chest/abdomen, ultrasonography (USG) abdomen, USG cranium, liver function tests and renal function tests.


Neonatal thrombocytopenia, Preterm gestational age, Neonatal sepsis, Maternal risk factors, Intraventricular hemorrhage, Respiratory distress syndrome

Full Text:



Nathan DG, Orkinstuart, A Thomas look. Nathan and oski’shematology of infancy and childhood. 6th ed. Philadelphia: Saunders. 2003.

Murray NA, Roberts IA. Circulating megakaryocytes and their progenitors in early thrombocytopenia in preterm neonates. Pediatr Res. 1996;40(1):112-9.

Dame C. developmental biology of thrombopoietin in human foetus and neonate. Acta Pediatr. 2002;91(438):54-65.

Israels SJ, Rand ML, Michelson AD. Neonatal platelet function. Semin thrombhemost. 2003;29(4):363-72.

Uhrynowska M, Maslanka K, Zupanska B. neonatal thrombocytopenia: incidence, serological and clinical observations. Am J Perinatal. 1997;14(7):415-8.

Mehta P, Rohitkumar V, Neumann L. Thrombocytopenia in the high-risk infant. J Pediatr. 1980;97:791-4.

Watts TL, Murray NA, Roberts IAG. Thrombopoietin has a primary role in the regulation of platelet production in preterm babies. Pediatr Res. 1999;46:28-32.

Israels SJ, Odaibo FS, Robertson C, McMillan EM, McNicol A. Deficient thromboxane synthesis and response in platelets from premature infants. Pediatr Res. 1997;41(2):218-23.

Rajasekhar D, Barnard MR, Bednarek FJ, Michelson AD. Platelet hypo reactivity in very low birth weight neonates. Thromb Haemost. 1997;77(5):1002-7.

Sitaru AG, Holzhauer S, Speer CP. Neonatal platelets from cord blood and peripheral blood. Platelets. 2005;16(3-4):203-10.